In humans, visceral adipose tissue is associated with insulin resistance, dyslipidaemia and Type 2 diabetes, while subcutaneous adipose tissue is associated with preserved insulin sensitivity and mitigates risk of metabolic disorders [30,31,32]. This evidence concerns the gene INS and Other metabolic disease.